Cargando…
Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations
Prostacyclin pathway agents are a critical treatment for patients with pulmonary arterial hypertension. Seven prostacyclin pathway agents are available, including agents administered by parenteral infusion, by inhalation, and orally. Pulmonary arterial hypertension patients are now transitioned from...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297490/ https://www.ncbi.nlm.nih.gov/pubmed/32595933 http://dx.doi.org/10.1177/2045894020931324 |